|
21.01.2016 08:57:00
|
Mainstay Medical: Notification of Transactions of (1) Persons Discharging Managerial Responsibility and (2) Persons closely associated with Persons Discharging Managerial Responsibility
Regulatory News:
This form is intended for use by an issuer making a notification required by Rules 7.2 and 7.3 of the Central Bank of Ireland’s Market Abuse Rules in relation to a person falling within either of the above categories of individual. These categories are defined in Regulation 12 (8) of the Market Abuse (Directive 2003/6/EC) Regulations 2005 and are detailed as part of this form.
All relevant boxes should be completed in block capital letters.
| 1 |
Name of the Issuer
Mainstay Medical International plc (the "Company”) |
2 |
Name of person discharging managerial responsibilities
Mr. Peter Crosby |
||||
| 3 |
State whether notification relates to a person closely associated
with a person discharging managerial responsibilities named in 2 and
identify the connected person
No |
4 |
Indicate whether the notification is in respect of a holding of the
person referred to in 2 or 3 above or in respect of a non-beneficial
interest
Notification is in respect of a grant of share options over Company Ordinary Shares to Mr. Crosby pursuant to the Company’s 2014 Share Option Plan |
||||
| 5 |
Description of shares or derivatives or other financial instruments
linked to them
Share options over Company Ordinary Shares |
6 |
Name of registered shareholder(s) and, if more than one, number of
shares or derivatives or other financial instruments linked to them,
held by each shareholder
Mr. Peter Crosby |
||||
| 7 |
State the nature of the transaction
Grant of share options over Company Ordinary Shares to Mr. Crosby pursuant to the Company’s 2014 Share Option Plan, on 17 December 2015 |
8 |
Number of shares, derivatives or other financial instruments linked
to them acquired
35,000 |
||||
| 9 |
Number of shares, derivatives or other financial instruments linked
to them disposed of
None |
10 |
Price per share or derivative or other financial instrument linked
to them or value of transaction
The exercise price relating to the share options is €17.95 in accordance with the Company’s 2014 Share Option Plan |
||||
| 11 |
Date and place of transaction
Not applicable |
12 |
Date issuer informed of transaction
17 December 2015 |
||||
| 13 |
Any additional information
None |
14 |
Name of contact and telephone number for queries
Tom Maher Company Secretary Mainstay Medical International plc Direct: +353 1 8970257 Mobile: +353 87 8335658 |
||||
|
Name and signature of duly designated officer of issuer responsible for making notification
Tom Maher, Company Secretary
______________________________________________
Date of notification __20 January 2016__ |
|||||||
View source version on businesswire.com: http://www.businesswire.com/news/home/20160120006640/en/
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Mainstay Medical International Plcmehr Nachrichten
| Keine Nachrichten verfügbar. |
Analysen zu Mainstay Medical International Plcmehr Analysen
Nachrichten
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.